We are booked out almost years ahead, big pharma is ringing us up.
“Governments now are spending – and that’s why Open Orphan is so lucky – they are spending tens of millions around the world developing and looking at where will the next pandemic come from. Let’s get the first line of defence, antivirals,” he says.
“Going forward, we are really busy working on next-generation vaccines.”
Nine vaccines have so far been approved under various regulatory regimes for use against Covid-19, and many others are in development.
“We are booked out almost years ahead, big pharma is ringing us up ‘can you run a trial in an RSV [respiratory syncytial virus] vaccine?’. Yep, no problem.”